Business Context and Reporting Period
Company: NL Industries, Inc. (NYSE: NL)
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2009
Business Model: NL Industries is primarily a holding company. Its operations are conducted through two main segments:
- Component Products: Operated through majority-owned subsidiary CompX International Inc. (87% owned). CompX manufactures security products, precision ball bearing slides, and marine components.
- Chemicals: Operated through a non-controlling interest in Kronos Worldwide, Inc. (36% owned). Kronos is a global producer of titanium dioxide (TiO2) pigments.
Key Financial Metrics (2009)
| Metric | 2009 Value | 2008 Value |
|---|---|---|
| Net Sales | $116.1 million | $165.5 million |
| Net Income (Loss) | $(12.0) million | $32.8 million |
| Net Income (Loss) Attributable to NL Stockholders | $(11.8) million | $33.2 million |
| Diluted EPS | $(0.24) | $0.68 |
| Operating Cash Flow | $1.4 million | $0.8 million |
| Total Assets | $403.0 million | $419.5 million |
| Long-term Debt (Parent) | $42.2 million | $43.0 million |
| Stockholders' Equity | $174.6 million | $188.4 million |
Note: Kronos debt is not consolidated on NL's balance sheet but is disclosed as approximately $613.2 million in the text.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased 30% to $116.1 million, driven by a 30% drop in CompX sales due to unfavorable economic conditions in North America (specifically office furniture and marine sectors) and a 13% drop in Kronos sales due to global demand weakness.
- Profitability Reversal: The company swung from a net income of $32.8 million in 2008 to a net loss of $12.0 million in 2009.
- CompX: Recorded an operating loss of $4.0 million (vs. $5.3 million income in 2008) due to lower volumes and patent litigation expenses.
- Kronos: Equity in earnings turned to a loss of $12.5 million (vs. $3.2 million income in 2008) due to production curtailments and unabsorbed fixed costs.
- One-Time Items: 2008 results were bolstered by a $48.8 million litigation settlement gain. 2009 included a smaller $11.3 million litigation settlement gain and a $0.7 million write-down of assets held for sale.
- Dividends: Kronos suspended its quarterly dividend in 2009. NL Industries maintained its quarterly dividend of $0.125 per share.
Guidance, Outlook, and Risks
Outlook for 2010:
- Management expects net income to be higher in 2010 than 2009, driven by higher component products income, higher equity earnings from Kronos, and higher litigation settlement gains.
- Kronos: Anticipates higher TiO2 sales volumes and average selling prices. Capacity utilization is expected to rise to 90-95% (up from 76% in 2009). A non-cash income tax benefit of approximately $35.2 million is expected in Q1 2010.
- CompX: Expects continued slow demand but aims to gain market share and improve productivity through lean manufacturing.
Key Risks and Contingencies:
- Lead Pigment Litigation: Significant ongoing litigation regarding former lead pigment operations. No accruals are currently recorded as liability is not probable or estimable, but potential liability could be material.
- Environmental Matters: Accrued environmental costs were $45.8 million at year-end. The upper end of the reasonably possible range is approximately $81 million.
- Legal Proceedings: A jury verdict in a dispute with former minority shareholders of a subsidiary resulted in a judgment of approximately $100 million (reduced from $145 million punitive damages), which the company is appealing.
- Liquidity: CompX's ability to borrow under its credit facility is restricted by financial covenants due to recent losses, though no borrowings were outstanding at year-end.
Investor Verification Checklist
- Lead Paint Liability: Verify the status of ongoing lead pigment litigation and the company's assessment of potential liability, given the lack of current accruals.
- Kronos Tax Benefit: Confirm the realization of the expected $35.2 million non-cash tax benefit in Q1 2010 related to German tax authorities.
- CompX Covenant Compliance: Monitor CompX's ability to meet the EBITDA-to-interest covenant on its credit facility, which restricted borrowing in late 2009.
- Environmental Accruals: Review the range of potential environmental costs ($46 million accrued vs. $81 million upper range) and any new site investigations.
- Patent Litigation: Track the outcome of the Humanscale patent infringement case where CompX was awarded over $19 million in damages (subject to appeal).